Gastric Volvulus Treatment Market Outlook 2026–2030: Growth Trends, Market Dynamics And Emerging Opportunities

Global Gastric Volvulus Treatment Market

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Gastric Volvulus Treatment Market Size Forecast: How Big Could The Market Get By 2030?

The gastric volvulus treatment market size has shown strong growth in recent years. It is forecast to increase from $28.86 billion in 2025 to $30.8 billion in 2026, registering a compound annual growth rate (CAGR) of 6.7%. Historically, this growth can be attributed to the availability of surgical treatment options, the expansion of hospital emergency care, diagnosis facilitated by imaging tests, the advancement of gastropexy procedures, and improvements in surgical expertise.

The gastric volvulus treatment market size is anticipated to observe significant growth in the coming years. It is predicted to reach $39.4 billion by 2030, with a compound annual growth rate (CAGR) of 6.3%. The growth during the projected period can be ascribed to the rise in minimally invasive surgery, advancements in emergency response systems, the utilization of advanced imaging, the expansion of specialty surgical centers, and increased clinical understanding. Key trends for the forecast period include a heightened preference for surgical intervention, greater adoption of minimally invasive procedures, improved emergency diagnosis and management, the broadening of specialized surgical care, and an emphasis on swift treatment to mitigate mortality rates.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=26903520&type=smp&name=Gastric%20Volvulus%20Treatment%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Gastric Volvulus Treatment Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

The escalating geriatric population is anticipated to drive the expansion of the gastric volvulus treatment market in the coming years. This demographic encompasses adults aged 65 years and beyond, who are susceptible to various health conditions due to diminished immunity and advancing age. Gastric volvulus particularly affects older adults over the age of 50. Therefore, an uptick in the geriatric population is expected to boost this market. A notable illustration can be seen in January 2024, where statistics from the Population Reference Bureau (PRB), a US-based nonprofit organization, forecast that the American population aged 65 and older will rise from 58 million in 2022 to 82 million in 2050, marking a 47% increase, and their representation in the overall population will expand from 17% to 23%. Consequently, the increasing geriatric populations are fueling the gastric volvulus treatment market.

Gastric Volvulus Treatment Market Segment Landscape And Growth Outlook

The gastric volvulus treatment market covered in this report is segmented –

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus

2) By Treatment Type: Medication, Surgery

3) By Route Of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy

2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques

Gastric Volvulus Treatment Market Innovation Trends: What Developments Are Reshaping The Industry?

Leading companies within the gastric volvulus treatment market are focusing on developing innovative solutions, such as next-generation oral immunomodulatory therapies, to address the increasing demand for advanced treatment options that enhance long-term disease management and improve patients’ quality of life. These orally administered therapies target inflammatory and immune-driven mechanisms, providing a more convenient and precise alternative compared with traditional systemic treatments, which often carry higher side-effect risks and necessitate more intensive oversight. For example, in October 2023, Pfizer Inc., a US-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved VELSIPITY (etrasimod). VELSIPITY (etrasimod) is a once-daily oral sphingosine-1-phosphate (S1P) receptor activator intended for individuals with moderate to severe active ulcerative colitis (UC). The official suggested dosage for VELSIPITY is 2 mg. ELSIPITY allows adults with moderately to severely active UC to achieve steroid-free resolution using an oral, once-daily pill that demonstrates a positive benefit-risk profile. The FDA’s approval of VELSIPITY today signifies an important turning point for UC patients seeking novel therapies for this long-term illness and who are ready to commence advanced treatment.

Gastric Volvulus Treatment Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the gastric volvulus treatment market are Medtronic plc, Johnson & Johnson Services Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co KG, Cook Group Incorporated, B Braun Melsungen AG, ConMed Corporation, Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Ambu A S, Richard Wolf GmbH, USGI Medical, Ovesco Endoscopy AG, Endo Tools Therapeutics SA, ErgoSuture, Sutrue Ltd, Golden Stapler Surgical Co Ltd, TransEnterix Inc.

View The Full Gastric Volvulus Treatment Market Report:

https://thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Gastric Volvulus Treatment Market Regional Analysis And Top Geography

North America was the largest region in the gastric volvulus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model